Bio-Techne and Kantaro Biosciences to launch a quantitative research use only COVID-19 serology test
On Aug. 3, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On Aug. 3, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On Jul. 21, 2020, PerkinElmer announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2…
On May 21, 2020, bioMerieux announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to detect antibodies in people…
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…